Gaois

Search direction

Search mode

Filter results

Collections

4 results in 4 documents

  1. #2406075

    Rphost: mab@silibank.net.kp

    Email: mab@silibank.net.kp

    Council Decision (CFSP) 2022/1336 of 28 July 2022 amending Decision (CFSP) 2016/849 concerning restrictive measures against the Democratic People’s Republic of Korea

  2. #2490773

    Rphost: mab@silibank.net.kp

    Email: mab@silibank.net.kp

    Council Implementing Regulation (EU) 2022/1331 of 28 July 2022 implementing Regulation (EU) 2017/1509 concerning restrictive measures against the Democratic People’s Republic of Korea

  3. #2542690

    Chun críocha cheannteideal 3002, tá feidhm ag an abairt 'táirgí imdhíonachta' maidir le peiptídí agus próitéiní (seachas na hearraí atá faoi cheannteideal 2937) a bhfuil baint dhíreach acu le próisis imdhíonachta a rialú, amhail antasubstaintí monaclónacha (MAB), bloghanna antasubstaintí, comhchuingigh antasubstaintí agus comhchuingigh bloghanna antasubstaintí, idirleoicíní (IFN), ceimicíní agus fachtóirí siad-neacróise áirithe (TNF), fachtóirí fáis (GF), haematopóéisiní agus fachtóirí spreagtha coilíneachtaí (CSF).

    For the purposes of heading 3002, the expression ‘immunological products’ applies to peptides and proteins (other than goods of heading 2937) which are directly involved in the regulation of immunological processes, such as monoclonal antibodies (MAB), antibody fragments, antibody conjugates and antibody fragment conjugates, interleukins, interferons (IFN), chemokines and certain tumour-necrosis factors (TNF), growth factors (GF), hematopoietins and colony-stimulating factors (CSF).

    Commission Implementing Regulation (EU) 2022/1998 of 20 September 2022 amending Annex I to Council Regulation (EEC) No 2658/87 on the tariff and statistical nomenclature and on the Common Customs Tariff

  4. #3012808

    Chun críocha cheannteideal 3002, tá feidhm ag an abairt 'táirgí imdhíonachta' maidir le peiptídí agus próitéiní (seachas na hearraí atá faoi cheannteideal 2937) a bhfuil baint dhíreach acu le próisis imdhíonachta a rialú, amhail antasubstaintí monaclónacha (MAB), bloghanna antasubstaintí, comhchuingigh antasubstaintí agus comhchuingigh bloghanna antasubstaintí, idirleoicíní (IFN), ceimicíní agus fachtóirí siad-neacróise áirithe (TNF), fachtóirí fáis (GF), haematopóéisiní agus fachtóirí spreagtha coilíneachtaí (CSF).

    For the purposes of heading 3002, the expression ‘immunological products’ applies to peptides and proteins (other than goods of heading 2937) which are directly involved in the regulation of immunological processes, such as monoclonal antibodies (MAB), antibody fragments, antibody conjugates and antibody fragment conjugates, interleukins, interferons (IFN), chemokines and certain tumour-necrosis factors (TNF), growth factors (GF), hematopoietins and colony-stimulating factors (CSF).

    Commission Implementing Regulation (EU) 2023/2364 of 26 September 2023 amending Annex I to Council Regulation (EEC) No 2658/87 on the tariff and statistical nomenclature and on the Common Customs Tariff